{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:13:56Z","timestamp":1790194436277,"version":"4.1.0"},"reference-count":59,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,25]]},"DOI":"10.18632\/oncotarget.15994","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T23:33:51Z","timestamp":1489016031000},"page":"29013-29027","source":"Crossref","is-referenced-by-count":55,"title":["\u03b12,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Kuo-Chang","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Lin","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shie-Liang","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Genomics Research Center, Academia Sinica, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Chou","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Kuang-Sheng Lee","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Stem Cell Research Center, National Yang-Ming University, Taipei, Taiwan"},{"name":"Taipei City Hospital, Taipei, Taiwan"},{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wen","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei, Taiwan"},{"name":"Department of Medical Research, China Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.18632\/oncotarget.6700","article-title":"Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma","volume":"7","author":"Yen","year":"2016","journal-title":"Oncotarget"},{"key":"3","doi-asserted-by":"crossref","first-page":"e1633","DOI":"10.1097\/MD.0000000000001633","article-title":"The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tjog.2014.06.002","article-title":"Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas","volume":"53","author":"Wang","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"5","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1200\/JCO.2000.18.24.4038","article-title":"Phase II feasibility study of sequential couplets of Cisplatin\/Topotecan followed by paclitaxel\/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study","volume":"18","author":"Vermorken","year":"2000","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ncponc0637","article-title":"Ovarian cancer: a focus on management of recurrent disease","volume":"3","author":"Pothuri","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2011.02.020","article-title":"MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis","volume":"121","author":"Rancourt","year":"2011","journal-title":"Gynecol Oncol"},{"key":"8","first-page":"741","article-title":"the year of sialyltransferases","volume":"5","author":"Delannoy","year":"1994","journal-title":"Glycobiology"},{"key":"9","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1073\/pnas.69.7.1838","article-title":"Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase","volume":"69","author":"Buck","year":"1972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/glycob\/3.3.201","article-title":"Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity","volume":"3","author":"Lambre","year":"1993","journal-title":"Glycobiology"},{"key":"11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.2002.6714","article-title":"Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis","volume":"86","author":"Yuan","year":"2002","journal-title":"Gynecol Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/glycob\/cwi063","article-title":"The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach","volume":"15","author":"Oriol","year":"2005","journal-title":"Glycobiology"},{"key":"13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1432-1033.2003.03458.x","article-title":"Identification and functional expression of a second human beta-galactoside alpha2,6-sialyltransferase, ST6Gal II","volume":"270","author":"Delannoy","year":"2003","journal-title":"Eur J Biochem"},{"key":"14","doi-asserted-by":"crossref","first-page":"45719","DOI":"10.1074\/jbc.M206808200","article-title":"Characterization of the second type of human beta-galactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes","volume":"277","author":"Tsujimoto","year":"2002","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11010-009-0147-9","article-title":"Human beta-galactoside alpha-2,3-sialyltransferase (ST3GalIII) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity","volume":"331","author":"Safa","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2005.07.016","article-title":"Altered mRNA expressions of sialyltransferases in ovarian cancers","volume":"99","author":"Yuan","year":"2005","journal-title":"Gynecol Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-1-3","article-title":"ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function","volume":"1","author":"Bellis","year":"2008","journal-title":"J Ovarian Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1006\/bbrc.2001.5002","article-title":"a potent and specific sialyltransferase inhibitor","volume":"284","author":"Soyasaponin","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2004.10.010","article-title":"Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids","volume":"96","author":"Tsai","year":"2005","journal-title":"Gynecol Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2005.12.216","article-title":"Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells","volume":"341","author":"Tsai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"21","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1073\/pnas.1503262112","article-title":"N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes","volume":"112","author":"Vattulainen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Sliwkowski","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: at last, cancer therapy meets systems biology","volume":"12","author":"Pines","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.18632\/oncotarget.7465","article-title":"Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy","volume":"8","author":"Damia","year":"2017","journal-title":"Oncotarget"},{"key":"25","doi-asserted-by":"crossref","first-page":"e000081","DOI":"10.1136\/esmoopen-2016-000081","article-title":"Unravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment options","volume":"1","author":"Besse","year":"2016","journal-title":"ESMO Open"},{"key":"26","doi-asserted-by":"crossref","first-page":"e000060","DOI":"10.1136\/esmoopen-2016-000060","article-title":"Mechanisms of resistance to EGFR-targeted drugs: lung cancer","volume":"1","author":"Ciardiello","year":"2016","journal-title":"ESMO Open"},{"key":"27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Tortora","year":"2008","journal-title":"N Engl J Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.biophys.37.032807.125829","article-title":"Structure-based view of epidermal growth factor receptor regulation","volume":"37","author":"Ferguson","year":"2008","journal-title":"Annu Rev Biophys"},{"key":"29","doi-asserted-by":"publisher","first-page":"28881","DOI":"10.18632\/oncotarget.7591","article-title":"Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells","volume":"7","author":"Leung","year":"2016","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.1507329112","article-title":"Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition","volume":"112","author":"Wong","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"31","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bcp.2012.01.007","article-title":"Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells","volume":"83","author":"Lee","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"32","doi-asserted-by":"crossref","first-page":"e0136893","DOI":"10.1371\/journal.pone.0136893","article-title":"Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells","volume":"10","author":"Samudio-Ruiz","year":"2015","journal-title":"PLoS One"},{"key":"33","doi-asserted-by":"publisher","first-page":"26142","DOI":"10.18632\/oncotarget.4536","article-title":"Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"34","first-page":"568938","article-title":"Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges","volume":"2010","author":"Mills","year":"2010","journal-title":"J Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1158\/1078-0432.CCR-05-1436","article-title":"Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer","volume":"11","author":"Dimopoulos","year":"2005","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.canep.2012.06.005","article-title":"The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer","volume":"36","author":"Shen","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0065-230X(08)60215-8","article-title":"Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens","volume":"52","author":"Hakomori","year":"1989","journal-title":"Adv Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0300-9084(01)01301-3","article-title":"The human sialyltransferase family","volume":"83","author":"Delannoy","year":"2001","journal-title":"Biochimie"},{"key":"39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1023\/A:1022288022969","article-title":"Sialyltransferases in cancer","volume":"18","author":"Chiricolo","year":"2001","journal-title":"Glycoconj J"},{"key":"40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1023\/A:1018532409041","article-title":"Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer","volume":"14","author":"Kannagi","year":"1997","journal-title":"Glycoconj J"},{"key":"41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/bbrc.1993.1830","article-title":"Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase","volume":"194","author":"Paulson","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"42","doi-asserted-by":"crossref","first-page":"21004","DOI":"10.1016\/S0021-9258(19)36789-4","article-title":"Cloning and expression of the Gal beta 1, 3GalNAc alpha 2,3-sialyltransferase","volume":"267","author":"Paulson","year":"1992","journal-title":"J Biol Chem"},{"key":"43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/glycob\/9.12.1307","article-title":"An alpha2,3 sialyltransferase (ST3GalI) is elevated in primary breast carcinomas","volume":"9","author":"Taylor-Papadimitriou","year":"1999","journal-title":"Glycobiology"},{"key":"44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-9-357","article-title":"ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines","volume":"9","author":"Dall\u2019Olio","year":"2009","journal-title":"BMC Cancer"},{"key":"45","first-page":"797","article-title":"Up-regulation of a set of glycosyltransferase genes in human colorectal cancer","volume":"78","author":"Narimatsu","year":"1998","journal-title":"Lab Invest"},{"key":"46","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1021\/np50090a011","article-title":"Anti-tumor-promoting activities of afromosin and soyasaponin I isolated from Wistaria brachybotrys","volume":"55","author":"Iwashima","year":"1992","journal-title":"J Nat Prod"},{"key":"47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF-ERBB signalling: towards the systems level","volume":"7","author":"Yarden","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"48","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1002\/pmic.200800204","article-title":"Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network","volume":"8","author":"Huber","year":"2008","journal-title":"Proteomics"},{"key":"49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2014.104","article-title":"Acquired resistance to TKIs in solid tumours: learning from lung cancer","volume":"11","author":"Sequist","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"50","first-page":"re6","article-title":"Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer","volume":"6","author":"Engelman","year":"2013","journal-title":"Sci Signal"},{"key":"51","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-06-3023","article-title":"The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion","volume":"67","author":"Taniguchi","year":"2007","journal-title":"Cancer research"},{"key":"52","doi-asserted-by":"crossref","first-page":"14920","DOI":"10.1021\/bi050751j","article-title":"Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor","volume":"44","author":"Staros","year":"2005","journal-title":"Biochemistry"},{"key":"53","doi-asserted-by":"crossref","first-page":"21988","DOI":"10.1074\/jbc.M003400200","article-title":"The Asn-420-linked sugar chain in human epidermal growth factor receptor suppresses ligand-independent spontaneous oligomerization. Possible role of a specific sugar chain in controllable receptor activation","volume":"275","author":"Taniguchi","year":"2000","journal-title":"J Biol Chem"},{"key":"54","doi-asserted-by":"crossref","first-page":"11332","DOI":"10.1073\/pnas.1107385108","article-title":"Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells","volume":"108","author":"Wong","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"55","first-page":"479","article-title":"Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells","volume":"3","author":"Narahara","year":"2010","journal-title":"Mol Med Rep"},{"key":"56","first-page":"4722","article-title":"Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas","volume":"62","author":"Giordano","year":"2002","journal-title":"Cancer research"},{"key":"57","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/0008-5472.CAN-05-3694","article-title":"Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas","volume":"66","author":"Cho","year":"2006","journal-title":"Cancer research"},{"key":"58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.2547","article-title":"A prognostic gene expression index in ovarian cancer- validation across different independent data sets","volume":"218","author":"Lage","year":"2009","journal-title":"The Journal of pathology"},{"key":"59","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis","volume":"10","author":"Fishman","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T18:15:42Z","timestamp":1658772942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":59,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,25]]}},"alternative-id":["15994","28423672"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15994","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]}}}